Replies to post #478833 on NorthWest Biotherapeutics Inc (NWBO)

[The Danish Dude]

From what was discussed at this board earlier, there's a public list of drugs having entered into the MHRA approval process in England.

People may read into it what they want.

I - and probably all on this board - know, that Ex has no incentives reading positive news into anything.

Everything had to be interpreted into a lowest denominator outlook, that benefits believing a non successful trial outcome.

This board needs an antidote, an enema to that, and I pass forth the positive outlook, which I believe this statement supports.

You're free not to listen to me, as I do with Ex.

"Section 43 is a qualified exemption and a consideration of the public interest should be made. We have considered the public interest and cannot see any public interest argument that outweighs the commercial harm in alerting competitors to whether a rival product is trying to come onto the market or not."